Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Influence of long-term thromboprophylaxis with low-molecular-weight heparin (enoxaparin) on changes of bone metabolism markers in pregnant women

M. Sudrová, J. Kvasnička, Z. Kudrnová, Z. Zenáhlíková, J. Mazoch, R. Brzežková

. 2011 ; 17 (5) : 508-513.

Language English Country United States

Document type Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't

Persistent link   https://www.medvik.cz/link/bmc12022179

This is a first descriptive, retrospective, observational study aiming to evaluate the changes in bone turnover markers in pregnant women and to assess the effect of a long-term treatment with low-molecular-weight heparin (LMWH), specifically, enoxaparin. Study involved 50 pregnant Caucasian women with thrombophilia. The patients either received prophylactic enoxaparin once daily subcutaneously (N = 35) or were observed without treatment (N = 15). Concentrations of total serum alkaline phosphatase (total AP), bone alkaline phosphatase (bone AP), osteoprotegerin (OPG), and the receptor activator of nuclear factor κB ligand (RANKL) were measured at 15, 25, and 35 weeks of gestation. Total serum AP increased with gestational age. In the group treated with enoxaparin, the percentage of bone AP concentration was lower (P < .05) than in the control group. Serum OPG also increased with gestational age, but no significant difference was found between the groups with- and without treatment. Despite the OPG increased, RANKL did not change.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc12022179
003      
CZ-PrNML
005      
20160201082956.0
007      
ta
008      
120806s2011 xxu f 000 0#eng||
009      
AR
024    7_
$a 10.1177/1076029610376628 $2 doi
035    __
$a (PubMed)20682598
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Sudrová, Magda $7 xx0143938 $u Thrombotic Center and Central Hematological Laboratory, General University Hospital in Prague, Czech Republic
245    10
$a Influence of long-term thromboprophylaxis with low-molecular-weight heparin (enoxaparin) on changes of bone metabolism markers in pregnant women / $c M. Sudrová, J. Kvasnička, Z. Kudrnová, Z. Zenáhlíková, J. Mazoch, R. Brzežková
520    9_
$a This is a first descriptive, retrospective, observational study aiming to evaluate the changes in bone turnover markers in pregnant women and to assess the effect of a long-term treatment with low-molecular-weight heparin (LMWH), specifically, enoxaparin. Study involved 50 pregnant Caucasian women with thrombophilia. The patients either received prophylactic enoxaparin once daily subcutaneously (N = 35) or were observed without treatment (N = 15). Concentrations of total serum alkaline phosphatase (total AP), bone alkaline phosphatase (bone AP), osteoprotegerin (OPG), and the receptor activator of nuclear factor κB ligand (RANKL) were measured at 15, 25, and 35 weeks of gestation. Total serum AP increased with gestational age. In the group treated with enoxaparin, the percentage of bone AP concentration was lower (P < .05) than in the control group. Serum OPG also increased with gestational age, but no significant difference was found between the groups with- and without treatment. Despite the OPG increased, RANKL did not change.
650    _2
$a dospělí $7 D000328
650    _2
$a alkalická fosfatasa $x krev $7 D000469
650    _2
$a antikoagulancia $x aplikace a dávkování $x škodlivé účinky $7 D000925
650    _2
$a kosti a kostní tkáň $x metabolismus $7 D001842
650    _2
$a enoxaparin $x aplikace a dávkování $x škodlivé účinky $7 D017984
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a gestační stáří $7 D005865
650    _2
$a lidé $7 D006801
650    _2
$a osteoprotegerin $x krev $7 D053244
650    _2
$a těhotenství $7 D011247
650    _2
$a hematologické komplikace těhotenství $x krev $x prevence a kontrola $7 D011250
650    _2
$a trimestry těhotenství $x krev $7 D011264
650    _2
$a ligand RANK $x krev $7 D053245
650    _2
$a retrospektivní studie $7 D012189
650    _2
$a trombofilie $x krev $x prevence a kontrola $7 D019851
655    _2
$a klinické zkoušky $7 D016430
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Kvasnička, Jan, $d 1943- $7 mzk2003187694 $u Thrombotic Center and Central Hematological Laboratory, General University Hospital in Prague, Czech Republic
700    1_
$a Kovářová Kudrnová, Zuzana $7 xx0167016 $u Thrombotic Center and Central Hematological Laboratory, General University Hospital in Prague, Czech Republic
700    1_
$a Zenáhlíková, Zuzana $7 xx0281967 $u Thrombotic Center and Central Hematological Laboratory, General University Hospital in Prague, Czech Republic
700    1_
$a Mazoch, Jiří $7 _BN003617 $u Thrombotic Center and Central Hematological Laboratory, General University Hospital in Prague, Czech Republic
700    1_
$a Brzežková, Radka $7 xx0281968 $u Thrombotic Center and Central Hematological Laboratory, General University Hospital in Prague, Czech Republic
773    0_
$w MED00001108 $t Clinical and applied thrombosis/hemostasis $x 1938-2723 $g Roč. 17, č. 5 (2011), s. 508-513
856    41
$u https://pubmed.ncbi.nlm.nih.gov/20682598 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y m $z 0
990    __
$a 20120806 $b ABA008
991    __
$a 20160201083127 $b ABA008
999    __
$a ok $b bmc $g 944092 $s 779476
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2011 $b 17 $c 5 $d 508-513 $i 1938-2723 $m Clinical and applied thrombosis/hemostasis $n Clin Appl Thromb Hemost $x MED00001108
LZP    __
$b NLK111 $a Pubmed-20120806/12/01

Find record

Citation metrics

Archiving options